Clinical Trial Update: Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis [NA]

View source ↗

Summary

A clinical trial evaluating gamma-linolenic acid for juvenile idiopathic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Gamma-linolenic acid (gamma-linolenic acid)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Juvenile Rheumatoid Arthritis | NA | Status: COMPLETED